share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券
美股sec公告 ·  05/02 22:08
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. Director Sangeeta N. Bhatia is set to sell 467 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $188,177.65, were acquired on 05/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Bhatia in the past three months, according to the provided records.
Vertex Pharmaceuticals Inc. Director Sangeeta N. Bhatia is set to sell 467 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market value of $188,177.65, were acquired on 05/01/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Bhatia in the past three months, according to the provided records.
根據最新文件，Vertex Pharmicals Inc.董事桑吉塔·巴蒂亞定於2024年2月5日出售467股普通股。這些股票的總市值爲188,177.65美元，作爲發行人補償的一部分，於2024年1月5日通過限制性股票歸屬收購。根據提供的記錄，這筆交易是在過去三個月中巴蒂亞沒有出售任何證券的時期之後進行的。
根據最新文件，Vertex Pharmicals Inc.董事桑吉塔·巴蒂亞定於2024年2月5日出售467股普通股。這些股票的總市值爲188,177.65美元，作爲發行人補償的一部分，於2024年1月5日通過限制性股票歸屬收購。根據提供的記錄，這筆交易是在過去三個月中巴蒂亞沒有出售任何證券的時期之後進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。